Summary |
|
1 | (50) |
1 Evidence Development for Healthcare Decisions: Improving Timeliness, Reliability, and Efficiency |
|
51 | (36) |
|
|
51 | (1) |
|
EBM and Clinical Effectiveness Research, |
|
|
52 | (8) |
|
Perspectives on Clinical Effectiveness Research, |
|
|
60 | (1) |
|
Clinical Effectiveness Research: Past, Present, and Future |
|
|
60 | (7) |
|
|
The Path to Research That Meets Evidence Needs |
|
|
67 | (20) |
|
2 Cases in Point: Learning from Experience |
|
87 | (68) |
|
|
87 | (2) |
|
Hormone Replacement Therapy |
|
|
89 | (15) |
|
|
Drug-Eluting Coronary Stents |
|
|
104 | (11) |
|
|
|
115 | (10) |
|
|
Antipsychotic Therapeutics |
|
|
125 | (9) |
|
|
|
|
|
|
|
134 | (21) |
|
3 Taking Advantage of New Tools and Techniques |
|
155 | (66) |
|
|
155 | (2) |
|
Innovative Approaches to Clinical Trials, Robert M. Califf, |
|
|
157 | (10) |
|
Innovative Analytic Tools for Large Clinical and Administrative Data bases, Sebastian Schneeweiss, |
|
|
167 | (7) |
|
Adaptive and Bayesian Approaches to Study Design, Donald A. Berry and Frank T. McGraw, |
|
|
174 | (6) |
|
Simulation and Predictive Modeling, Mark S. Roberts and David M. Eddy, |
|
|
180 | (9) |
|
Emerging Genomic Information, Teri A. Manolio, |
|
|
189 | (32) |
4 Organizing and Improving Data Utility |
|
221 | (46) |
|
|
221 | (1) |
|
The Electronic Health Record and Care Reengineering: Performance Improvement Redefined |
|
|
222 | (15) |
|
|
|
|
|
|
|
Administrative Databases in Clinical Effectiveness Research |
|
|
237 | (5) |
|
|
Clinical Effectiveness Research: The Promise of Registries |
|
|
242 | (11) |
|
|
|
Distributed Data Networks |
|
|
253 | (14) |
|
5 Moving to the Next Generation of Studies |
|
267 | (56) |
|
|
267 | (2) |
|
Large Data Streams and the Power of Numbers |
|
|
269 | (7) |
|
|
|
276 | (5) |
|
|
Enhancing the Evidence to Improve Practice: Experimental and Hybrid Studies |
|
|
281 | (13) |
|
|
Accommodating Genetic Variation as a Standard Feature of Clinical Research |
|
|
294 | (5) |
|
|
Phased Introduction and Payment for Interventions Under Protocol |
|
|
299 | (8) |
|
|
|
307 | (16) |
|
|
6 Aligning Policy with Research Opportunities |
|
323 | (40) |
|
|
323 | (2) |
|
|
325 | (6) |
|
|
Pharmaceutical Industry Data |
|
|
331 | (3) |
|
|
Regulatory Requirements and Data Generation |
|
|
334 | (5) |
|
|
Ensuring Optimal Use of Data Generated by Public Investment |
|
|
339 | (4) |
|
|
Building the Research Infrastructure |
|
|
343 | (10) |
|
|
|
353 | (10) |
|
|
|
7 Organizing the Research Community for Change |
|
363 | (18) |
|
|
363 | (1) |
|
Increasing Knowledge from Practice-Based Research, |
|
|
364 | (1) |
|
Opportunities for Action (Panel Discussion) |
|
|
365 | (5) |
|
|
|
|
|
|
|
370 | (4) |
|
Issues for Possible Roundtable Follow-Up, |
|
|
374 | (7) |
Appendixes |
|
|
|
381 | (6) |
|
B Biographical Sketches of Participants |
|
|
387 | (22) |
|
|
409 | |